With the deep analysis of the above options, it is suggested that the company needs to choose the alternative 3 in order to keep a competitive position in the long run. As the alternative 3 would allow the company to not just introduce brand-new and innovative products in the market it would also lower the high expenses on R&D under alternative 2 and increase the revenue margins. It would allow the company to increase its share rates as well, as investors want to invest more in business with substantial R&D spending and increase in the overall worth of the company.
Action and implementation Strategy
Technique can be carried out successfully by establishing certain short term along with long term plans. These plans could be as follows;
Short Term Plan (0-1 year)
• Under the short term strategy Glaxosmithkline And Aids Drugs Policy should perform numerous activities to implement its NHW method efficiently. These activities are as follows;.
• Get the audit of its brand portfolio done, to analyze the core selling brands, which create most of its revenue.
• Examine the current target market along with the marketplace section which is not consist of in the company's circle.
• Evaluate the existing financial information to measure the amount that ought to be invested in the R&D and acquisitions.
• Evaluate the potential financiers and their nature, i.e. do they want long term benefits (capital gain), or the desire early profits (dividend). It would let the company to understand that just how much quantity needs to be invested in R&D.
Mid Term Plan (1-5 years)
• Obtain those organizations in which the company has possible experience to deal with. Get most beneficial companies with a strong commitment to health, to construct the customer's understandings in the right direction.
• Focus more on acquisitions than R&D to construct the base in the consumer's mind about Glaxosmithkline And Aids Drugs Policy worths and vision and to avoid prospective risk of sunk expense.
Long Term Plan (1-10 years)
• Obtain organizations with health as well as taste factor, as the base for the Glaxosmithkline And Aids Drugs Policy as a business producing healthy products has been developed under midterm plan and now the company might move towards taste element also to understand the consumers, which focus more on taste rather than health.
• Be more aggressive towards R&D than the acquisitions, as it is the significant time to build new items.
